Basic Information
NH TherAguix is a medical startup headquartered in Lyon, France, established in December 2015, focusing on utilizing nanoradiotherapy to treat cancer. The company’s leading drug is a nanoparticle named AGuIX, designed to selectively target solid tumors to enhance its localization and radiotherapy efficacy after intravenous injection.
NH TherAguix SA
Provence-Alpes-Côted'Azur,France
less than 15 people
January 01, 2015
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios